AlzeCure Pharma AB
Share:
Subscribe:

Martin Jönsson, VD

Wed, Aug 25, 2021 08:00 CET

Martin Jönsson, VD

Medium resolution

Original resolution

Subscribe

Related Releases

AlzeCure to present abstract at ECNP conference on NeuroRestore project's potential in depression Thu, Aug 12, 2021 07:30 CET

AlzeCure publishes its interim report for January – September 2020 Tue, Nov 17, 2020 08:00 CET

AlzeCure receives approval to start clinical Phase I trial with ACD856 in Alzheimer's disease Thu, Nov 12, 2020 12:15 CET